Marc de Garidel

Director at Claris Biotherapeutics.

Raised on Claris Biotherapeutics filings

$5.6M

of $5.6M offered across 2 Form D filings

Form D filings: 2
Teammates: 6
Last filing: Sep 22, 2025

Company

Claris Biotherapeutics

Biotech · Jersey City, NJ

Eye drop biologic for neurotrophic keratitis

Eye drop biologic for neurotrophic keratitis

Investors: 6
Still open: $1

Investors: 6
Sector: Biotech
HQ: Jersey City, NJ

Claris Biotherapeutics filings

Claris Biotherapeutics Form D filings
Filed	Security	Sold of offered	Filing
Sep 22, 2025	Debt	$2.3M/ $2.3M	Form D
Mar 7, 2025	Debt	$3.3M/ $3.3M	Form D

DebtFiled Sep 22, 2025Form D
$2.3M/ $2.3M
DebtFiled Mar 7, 2025Form D
$3.3M/ $3.3M

Works with

Also named on Claris Biotherapeutics filings

Clarke AtwellPresident & Chief Executive Officer, Form D signerForm D signer Susan OrrExecutive Officer Henry RathExecutive Officer Kenneth HarrisonDirector Meredith FisherDirector Reza DanaDirector